Silent myocardial ischemia

Circulation Journal

Volumn 73, Issue 5, 2009, Pages 785-797

  Gutterman, David D ^a  

^a Medical College of Wisconsin   (United States)

Author keywords

Angina; Ischemia; Ischemic heart disease; Myocardial infarction

Indexed keywords

ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; NIFEDIPINE; NITRATE;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOLTER MONITORING; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; RADIOCARDIOGRAPHY; RATING SCALE; REVIEW; SILENT MYOCARDIAL INFARCTION; SILENT MYOCARDIAL ISCHEMIA; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; STROKE; THORAX PAIN;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; DEATH, SUDDEN, CARDIAC; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 65649118890     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1209     Document Type: Review

References (114)

1. World Health Organization Program Fact Sheet #310: 2004 Death Rates. WHO international web site 2008 October. Available at: URL: http://www.who.int/ mediacentre/factsheets/fs310/en/index.html
2. Ma E, Iso H, Takahashi H, Yamagishi K, Tanigawa T. Age-Period-Cohort analysis of mortality due to ischemic heart disease in Japan, 1955 to 2000. Circ J 2008; 72: 966-972.
3. NHLBI Factbook. National Heart Lung and Blood Institute Factbook 2007; 4 Available at: URL: http://www.nhlbi.nih.gov/about/factbook/chapter4.htm#4-1
4. Cerne A, Kranjec I. Atherosclerotic burden in coronary and peripheral arteries in patients with first clinical manifestation of coronary artery disease. Heart Vessels 2002; 16: 217-226. (Pubitemid 35244101)
5. Oberman A, Kouchoukos NT, Holt JH Jr, Russell RO Jr. Long-term results of the medical treatment of coronary artery disease. Angiology 1977; 28: 160-168. (Pubitemid 8083509)
6. Kannel WB. Silent myocardial ischemia and infarction: Insights from the Framingham study. Cardiology Clinics 1986; 4: 583-591. (Pubitemid 17230678)
7. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: An update on the framingham study. N Engl J Med 1984; 311: 1444-11147
8. Gottlieb SO, Gottlieb SH, Achuff SC, Baumgardner R, Mellits ED, Weisfeldt ML, et al. Silent ischemia on holter monitoring predicts mortality in high- risk postinfarction patients. JAMA 1988; 259: 1030-1035. (Pubitemid 18046851)
9. Ouyang P, Chandra NC, Gottlieb SO. Frequency and importance of silent myocardial ischemia identified with ambulatory electrocardiographic monitoring in the early in-hospital period after acute myocardial infarction. Am J Cardiol 1990; 65: 267-270. (Pubitemid 20038903)
10. Pepine CJ. Silent myocardial ischemia: Definition, magnitude, and scope of the problem. Cardiology Clinics 1986; 4: 577-581. (Pubitemid 17230677)
11. Komukai K, Ogawa T, Yagi H, Date T, Suzuki K, Sakamoto H, et al. Renal insufficiency is related to painless myocardial infarction. Circ J 2007; 71: 1366-1369. (Pubitemid 47378435)
12. Mickley H. Ambulatory st segment monitoring after myocardial infarction. Br Heart J 1994; 71: 113-114. (Pubitemid 24092689)
13. Amanullah AM, Lindvall K. Prevalence and significance of transient-predominantly asymptomatic-myocardial ischemia on holter monitoring in unstable angina pectoris, and correlation with exercise test and thallium-201 myocardial perfusion imaging. Am J Cardiol 1993; 72: 144-148. (Pubitemid 23205868)
14. Sharma B, Asinger RW, Francis GS, Hodges M, Wyeth RP. Demonstration of exercise-induced painless myocardial ischemia in survivors of out-of-hospital ventricular fibrillation. Am J Cardiol 1987; 59: 740-745. (Pubitemid 17061279)
15. Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R. Sudden coronary death: Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 1995; 92: 1701-1709.
16. Wilcox I, Freedman SB, Kelly DT, Harris PJ. Clinical significance of silent ischemia in unstable angina pectoris. Am J Cardiol 1990; 65: 1313-1316. (Pubitemid 20172496)
17. Deanfield JE, Maseri A, Selwyn AP, Ribeiro P, Chierchia S, Krikler S, et al. Myocardial ischaemia during daily life in patients with stable angina: Its relation to symptoms and heart rate changes. Lancet 1983; 2: 753-758.
18. Schang SJ Jr, Pepine CJ. Transient asymptomatic S-T segment depression during daily activity. Am J Cardiol 1977; 39: 396-402. (Pubitemid 8055355)
19. Cohn PF. Silent myocardial ischemia as a manifestation of asymptomatic coronary artery disease: What is appropriate therapy? Am J Cardiol 1985; 56: 28D-34D. (Pubitemid 15236472)
20. Cecchi AC, Dovellini EV, Marchi F, Pucci P, Santoro G, Fazzini PF. Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina. J Am Coll Cardiol 1983; 1: 934-939.
21. Makino N, Nakanishi H, Yosida S, Matsui H, Yanaga T. Alteration of heart membrane Ca2+ transport in streptotocin-induced diabetic cardiomyopathy. In: Nagano M, Dhalla NS, editors. The diabetic heart. 1 edn. New York: Raven Press; 1991; 219-228.
22. Sigwart U, Grbic M, Payot M, Goy JJ, Essinger A, Fischer A. Ischemic events during coronary artery balloon occlusion. In: Rutishauser W, Roskamm H, editors. Silent myocardial ischemia. Berlin: Springer-Verlag; 1984; 29-36.
23. Brown EJ Jr, Idoine J, Cohn PF. Regional ejection fraction during exercise: A quantitative measurement to localize coronary artery stenoses in patients with symptomatic or silent myocardial ischemia. Cardiology Clinics 1986; 4: 677-684. (Pubitemid 17230688)
24. Chierchia S, Lazzari M, Freedman SB, Brunelli C, Maseri A. Impairment of myocardial perfusion and function during painless myocardial ischemia. J Am Coll Cardiol 1983; 1: 924-930.
25. Glasser SP. The role of exercise testing in the identification of patients with silent myocardial ischemia. Cardiology Clinics 1986; 4: 705-715. (Pubitemid 17230691)
26. Burton KS, Johnson PC. Reactive hypermia in individual capillaries of skeletal muscle. Am J Physiol 1972; 223: 517-524.
27. Pepine CJ, Imperi GA, Lambert CR Jr. Detection of silent myocardial ischemia in patients with angina using continuous electrocardiographic monitoring. Cardiology Clinics 1986; 4: 627-633. (Pubitemid 17230683)
28. Coy KM, Imperi GA, Lambert CR Jr, Pepine CJ. Silent myocardial ischemia during daily activities in asymptomatic men with positive exercise test responses. Am J Cardiol 1987; 59: 45-49. (Pubitemid 17077062)
29. Rocco MB, Nabel EG, Selwyn AP. Development and validation of ambulatory monitoring to characterize ischemic heart disease out of hospital. Cardiology Clinics 1986; 4: 659-668. (Pubitemid 17230686)
30. Deanfield JE, Shea MJ, Ribiero P, de Landsheere CM, Wilson RA, Horlock P, et al. Transient ST-segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol 1984; 54: 1195-1200. (Pubitemid 15220538)
31. Mohiuddin IH, Tamaki N, Kambara H, Nohara R, Ono S, Okuda K, et al. Detection of exercise-induced silent ischemia and the sequence of ischemic events in coronary artery disease by radionuclide ambulatory ventricular function monitoring. Jpn Circ J 1994; 58: 689-697. (Pubitemid 24306483)
32. Malliani A. The elusive link between transient myocardial ischemia and pain. Circulation 1986; 73: 201-204. (Pubitemid 16127394)
33. Foreman RD, Blair RW, Ammons WS. Neural mechanisms of cardiac pain. In: Cervero F, Morrison JFB, editors. Visceral sensation, 1 edn. Amsterdam: Elsevier; 1986; 227-243.
34. Meller ST, Gebhart GF. A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain. Neurosci 1992; 48: 501-524.
35. Ammons WS, Blair RW, Foreman RD. Vagal afferent inhibition of spinothalamic cell responses to sympathetic afferents and bradykinin in the monkey. Circ Res 1983; 53: 603-612. (Pubitemid 14248485)
36. Uchida Y, Murao S. Excitation of afferent cardiac sympathetic nerve fibers during coronary occlusion. Am J Physiol 1974; 226: 1094-1099.
37. Ueda H, Uchida Y, Kamisaka K. Distribution and responses of the cardiac sympathetic receptors to mechanically induced circulatory changes. Jpn Heart J 1969; 10: 70-81.
38. Brown AM. Excitation of afferent cardiac sympathetic nerve fibres during myocardial ischemia. J Physiol 1967; 190: 35-53.
39. Baker DG, Coleridge HM, Coleridge JCG, Nerdrum T. Search for a cardiac nociceptor: Stimulation by bradykinin of sympathetic afferent nerve endings in the heart of the cat. J Physiol 1980; 306: 519-536. (Pubitemid 10005638)
40. Lindgren I, Olivecrona H. Surgical treatment of angina pectoris. J Neurosurg 1947; 4: 19-39.
41. Del Bianco PL, Del Bene E, Sicuteri F. Heart pain. Adv Neurol 1974; 4: 375-381.
42. Ammons WS. Cardiopulmonary sympathetic afferent excitation of lower thoracic spinoreticular and spinothalamic neurons. J Neurophysiol 1990; 64: 1907-1916.
43. Blair RW, Weber RN, Foreman RD. Responses of thoracic spinothalamic neurons to intracardiac injection of bradykinin in the monkey. Circ Res 1982; 51: 83-94. (Pubitemid 12092393)
44. Euchner-Wamser I, Meller ST, Gebhart GF. A model of cardiac nociception in chronically instrumented rats: Behavioral and electrophysiological effects of pericardial administration of algogenic substances. Pain 1994; 58: 117-128. (Pubitemid 24221825)
45. Pagani M, Pizzinelli P, Furlan R, Guzzetti S, Rimoldi O, Sandrone G, et al. Analysis of the pressor sympathetic reflex produced by intracoronary injections of bradykinin in conscious dogs. Circ Res 1985; 56: 175-183. (Pubitemid 15131379)
46. Gutterman DD, Pardubsky PD, Pettersen M, Marcus ML, Gebhart GF. Thoracic spinal neuron responses to repeated myocardial ischemia and epicardial bradykinin. Brain Res 1998; 790: 293-303. (Pubitemid 28234515)
47. Sutherland SP, Benson CJ, Adelman JP, McCleskey EW. Acid-sensing ion channel 3 matches the acid-gated current in cardiac ischemia-sensing neurons. Proc Natl Acad Sci USA 2001; 98: 711-716. (Pubitemid 32105108)
48. Verani MS, Mahmarian JJ, Hixson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990; 82: 80-87. (Pubitemid 20216318)
49. Sylven C, Beermann B, Jonzon B, Brandt R. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. BMJ (Clin Res Ed) 1986; 293: 227-230. (Pubitemid 16064218)
50. Crea F, Pupita G, Galassi AR, el-Tamimi H, Kaski JC, Davies G, et al. Role of adenosine in pathogenesis of anginal pain. Circulation 1990; 81: 164-172.
51. Pan H-L, Longhurst JC. Lack of a role of adenosine in activation of ischemically sensitive cardiac sympathetic afferents. Am J Physiol 1995; 269: H106-H113.
52. Ammons WS, Blair RW, Foreman RD. Responses of primate T1-T5 spinothalamic neurons to gallbladder distension. Am J Physiol 1984; 247: R995-R1002.
53. Foreman RD. Viscerosomatic convergence onto spinal neurons responding to afferent fibers in the inferior cardiac nerve. Brain Res 1977; 137: 164-168. (Pubitemid 8219560)
54. Qin C, Farber JP, Foreman RD. Gastrocardiac afferent convergence in upper thoracic spinal neurons: A central mechanism of postprandial angina pectoris. J Pain 2007; 8: 522-529. (Pubitemid 46843688)
55. Qin C, Foreman RD, Farber JP. Characterization of thoracic spinal neurons with noxious convergent inputs from heart and lower airways in rats. Brain Res 2007; 1141: 84-91. (Pubitemid 46365643)
56. Qin C, Chandler MJ, Foreman RD. Effects of urinary bladder distension on activity of T3-T4 spinal neurons receiving cardiac and somatic noxious inputs in rats. Brain Res 2003; 971: 210-220. (Pubitemid 36423322)
57. Nihoyannopoulos P, Marsonis A, Joshi J, Athanassopoulos G, Oakley CM. Magnitude of myocardial dysfunction is greater in painful than in painless myocardial ischemia: An exercise echocardiographic study. J Am Coll Cardiol 1995; 25: 1507-1512.
58. Taki J, Yasuda T, Flamm SD, Hutter A, Gold HK, Leinbach R, et al. Comparison of painful and painless left ventriclar dysfunction recorded during ambulatory ventricular function monitoring in angina pectoris secondary to coronary artey disease. Am J Cardiol 1992; 70: 1555-1558. (Pubitemid 23006067)
59. Gasperetti CM, Burwell LR, Beller GA. Prevalence of and variables associated with silent myocardial ischemia on exercise thallium-201 stress testing. J Am Coll Cardiol 1990; 16: 115-123. (Pubitemid 20217052)
60. Hecht HS, Shaw RE, Bruce T, Myler RK. Silent ischemia: Evaluation by exercise and redistribution tomographic thallium-201 myocardial imaging. J Am Coll Cardiol 1989; 14: 895-900. (Pubitemid 19250573)
61. Kohya T, Tomita F, Itoh K, Suzuki Y, Kawabata N, Andoh J, et al. Silent myocardial ischemia during Holter monitoring in ischemic heart disease. Jpn Circ J 1989; 53: 1399-1406. (Pubitemid 20115321)
62. Droste C, Roskamm H. Experimental pain measurements in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol 1983; 1: 940-945.
63. Falcone C, Sconocchia R, Guasti L, Codega S, Montemartini C, Specchia G. Dental pain threshold and angina pectoris in patients with coronary artery disease. J Am Coll Cardiol 1988; 12: 348-352. (Pubitemid 18192261)
64. Falcone C, Auguadro C, Sconocchia R, Catalano O, Ochan M, Angoli L, et al. Susceptibility to pain during coronary angioplasty: Usefulness of pulpal test. J Am Coll Cardiol 1996; 28: 903-909. (Pubitemid 26348155)
65. Falcone C, Guasti L, Ochan M, Codega S, Tortorici M, Angoli L, et al. Beta-endorphins during coronary angioplasty in patients with silent or symptomaqtic myocardial ischemia. J Am Coll Cardiol 1993; 22: 1614-1620. (Pubitemid 23336713)
66. Falcone C, Specchia G, Rondanelli R, Guasti L, Corsico G, Codega S, et al. Correlation between beta-endorphin plasma levels and anginal symptoms in patients with coronary artery disease. J Am Coll Cardiol 1988; 11: 719-723. (Pubitemid 18092178)
67. Heller GV, Garber CE, Connolly MJ, Allen-Rowlands CF, Siconolfi SF, Gann DS, et al. Plasma beta-endorphin levels in silent myocardial ischemia induced by exercise. Am J Cardiol 1987; 59: 735-739. (Pubitemid 17061278)
68. Ellestad MH, Kuan P. Naloxone and asymptomatic ischemia: Failure to induce angina during exercise testing. Am J Cardiol 1984; 54: 982-984. (Pubitemid 15211576)
69. Chiariello M, Indolfi C. Silent myocardial ischemia in patients with diabetes mellitus. Circulation 1996; 93: 2089-2091. (Pubitemid 26187096)
70. Barber MJ, Mueller TM, Henry DP, Felten SY, Zipes DP. Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 1983; 67: 787-795.
71. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: Assessment by exercise thallium scintigraphy. Ann Intern Med 1988; 108: 170-175. (Pubitemid 18081187)
72. Naka M, Hiramatsu K, Aizawa T, Momose A, Yoshizawa K, Shigematsu S, et al. Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J 1992; 123: 46-53.
73. Marchant B, Umachandran V, Stevenson R, Kopelman PG, Timmis AD. Silent myocardial ischemia: Role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 1993; 22: 1433-1437. (Pubitemid 23316370)
74. Umachandran V, Ranjadayalan K, Ambepityia G, Marchant B, Kopelman PG, Timmis AD. The perception of angina in diabetes: Relation to somatic pain threshold and autonomic function. Am Heart J 1991; 121: 1649-1654.
75. 123I-metaiodobenzylguanidine (MIBG) imaging. Circ J 2009; 73: 310-315.
76. Chipkin SR, Frid D, Alpert JS, Baker SP, Dalen JE, Aronin N. Frequency of painless myocardial ischemia during exercise tolerance testing in patients with and without diabetes mellitus. Am J Cardiol 1987; 59: 61-65. (Pubitemid 17077065)
77. Langer A, Freeman MR, Josse RG, Armstrong PW. Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995; 25: 610-618.
78. Faerman I, Faccio E, Milei J, Nuñez R, Jadzinsky M, Fox D, et al. Autonomic neuropathy and painless myocardial infarction in diabetic patients: Histologic evidence of their relationship. Diabetes 1977; 26: 1147-1458. (Pubitemid 8283436)
79. Barber MJ, Mueller TM, Davies BG, Gill RM, Zipes DP. Interruption of sympathetic and vagal-mediated afferent responses by transmural myocardial infarction. Circulation 1985; 72: 623-631. (Pubitemid 15242256)
80. Ciuffo AA, Ouyang P, Becker LC, Levin L, Weisfeldt ML. Reduction of sympathetic inotropic response after ischemia in dogs. J Clin Invest 1985; 75: 1504-1509.
81. Gutterman DD, Morgan DA, Miller FJ. Effect of brief myocardial ischemia on sympathetic coronary vasconstriction. Circ Res 1992; 71: 960-969.
82. Miyazaki T, Zipes DP. Presynaptic modulation of efferent sympathetic and vagal neurotransmission in the canine heart by hypoxia, high K+, low pH, and adenosine. Circ Res 1990; 66: 289-301.
83. Mitrani RD, Klein LS, Miles WM, Hackett FK, Burt RW, Wellman HN, et al. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 1993; 22: 1344-1353. (Pubitemid 23316357)
84. Pettersen MD, Abe T, Morgan DA, Gutterman DD. Role of adenosine in postischemic dysfunction of coronary innervation. Circ Res 1995; 76: 95-101.
85. Abe T, Morgan DA, Gutterman DD. Role of adenosine receptor subtypes in neural stunning of sympathetic coronary innervation. Am J Physiol 1997; 272: H25-H34. (Pubitemid 127750031)
86. Abe T, Morgan D, Sengupta JN, Gebhart GF, Gutterman DD. Attenuation of ischemia-induced activation of cardiac sympathetic afferents following brief myocardial ischemia in cats. J Auton Nerv Syst 1998; 71: 28-36. (Pubitemid 28359423)
87. Weiner DA, Ryan TJ, McCabe CH, Ng G, Chaitman BR, Sheffield LT, et al. Risk of developing an acute myocardial infarction or sudden coronary death in patients with exercise-induced silent myocardial ischemia: A report from the coronary artery surgery study (CASS) registry. Am J Cardiol 1988; 62: 1155-1158. (Pubitemid 18276978)
88. Matsuo S, Nakajima K, Horie M, Nakae I, Nishimura T. Prognostic value of normal stress myocardial perfusion imaging in Japanese population. Circ J 2008; 72: 611-617.
89. Wake R, Takeuchi M, Yoshikawa J, Yoshiyama M. Effects of gender on prognosis of patients with known or suspected coronary artery disease undergoing contrast-enhanced dobutamine stress echocardiography. Circ J 2007; 71: 1060-1066. (Pubitemid 46998020)
90. Toyoda T, Takeuchi T, Uchiyama T, Sato H, Takahashi N, Miura T, et al. The prognostic significance of exercise-induced silent ST-segment depression in patients after myocardial infarction. Jpn Circ J 1993; 57: 197-207. (Pubitemid 23179304)
91. Gill JB, Cairns JA, Roberts RS, Costantini L, Sealey BJ, Fallen EF, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med 1996; 334: 65-70. (Pubitemid 26017931)
92. Tzivoni D, Gavish A, Zin D, Gottlieb S, Moriel M, Keren A, et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol 1988; 62: 661-664. (Pubitemid 18237115)
93. Theroux P, Waters DD, Halphen C, Debaisieux JC, Mizgala HF. Prognostic value of exercise testing after myocardial infarction. N Engl J Med 1979; 301: 341-345. (Pubitemid 10242785)
94. Erceg P, Davidovic M, Vasiljevic Z, Mitrovic P, Vukcevic V, Zdravkovic S, et al. Long-term prognosis of patients with early post-infarction angina. Circ J 2007; 71: 1530-1533. (Pubitemid 47529651)
95. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol 1987; 10: 756-760. (Pubitemid 17163098)
96. Matsumoto N, Sato Y, Suzuki Y, Kasama S, Nakano Y, Kato M, et al. Incremental prognostic value of cardiac function assessed by ECG-gated myocardial perfusion SPECT for the prediction of future acute coronary syndrome. Circ J 2008; 72: 2035-2039.
97. Gandhi MM, Wood DA, Lampe FC. Characteristics and clinical significance of ambulatory myocardial ischemia in men and women in the general population presenting with angina pectoris. J Am Coll Cardiol 1994; 23: 74-81. (Pubitemid 24027194)
98. Klein J, Chao SY, Berman DS, Rozanski A. Is 'silent' myocardial ischemia really as severe as symptomatic ischemia: The analytical effect of patient selection biases. Circulation 1994; 89: 1958-1966. (Pubitemid 24142769)
99. Zygmunt PM, Edwards G, Weston AH, Davis SC, Högestätt ED. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br J Pharmacol 1996; 118: 1147-1152.
100. Quyyumi AA, Panza JA, Diodati JG, Callahan TS, Bonow RO, Epstein SE. Prognostic implications of myocardial ischemia during daily life in low risk patients with coronary artery disease. J Am Coll Cardiol 1993; 21: 700-708. (Pubitemid 23076288)
101. Cohn PF. Clinical importance of silent myocardial ischemia in asymptomatic subjects. Circulation 1990; 81: 691-693. (Pubitemid 20055979)
102. Deanfield JE, Detry JM, Lichtlen PR, Magnani B, Sellier P, Thaulow E. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: Double-blind circadian anti-ischemia program in Europe (Cape Trial). J Am Coll Cardiol 1994; 24: 1460-1467. (Pubitemid 24344240)
103. Frishman WH, Teicher M. Antianginal drug therapy for silent myocardial ischemia. Am Heart J 1987; 114: 140-147. (Pubitemid 17098553)
104. Hill JA, Pepine CJ. Treatment of silent myocardial ischemia. Cardiology Clinics 1986; 4: 685-695. (Pubitemid 17230689)
105. Portegies MCM, Sijbring P, Gobel EJAM, Viersma JW, Lie KI. Efficacy of metoprolol and diltiazem in treating silent myocardial ischemia. Am J Cardiol 1994; 74: 1095-1098. (Pubitemid 24366506)
106. Davies RF, Habibi H, Klinke WP, Dessain P, Nadeau C, Phaneuf DC, et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. J Am Coll Cardiol 1995; 25: 619-625.
107. Chaitman BR, Stone PH, Knatterud GL, Forman SA, Sopko G, Bourassa MG, et al. Asymptomatic cardiac ischemia pilot (ACIP) study: Impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercist test outcomes: The ACIP Investigators. J Am Coll Cardiol 1995; 26: 585-593.
108. Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: The SWISSI II randomized controlled trial. JAMA 2007; 297: 1985-1991. (Pubitemid 46740350)
109. Dargie HJ, Ford I, Fox KM. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina: The TIBET Study Group. Eur Heart J 1996; 17: 104-112. (Pubitemid 26111913)
110. Von Arnim T. Prognostic significance of transient ischemic episodes: Response to treatment shows improved prognosis: Results of the Total Ischemic Burden Bisoprolol Study (TIBBs) follow-up. J Am Coll Cardiol 1996; 28: 20-24. (Pubitemid 26266618)
111. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, et al. Asymptomatic cardiac ischemia pilot (acip) study: Outcome at 1 year for patients with acymptomatic cardiac ischemia randomized to medical therapy or revascularization: The ACIP Investigators. J Am Coll Cardiol 1995; 26: 594-605.
112. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997; 95: 2037-2043. (Pubitemid 27184271)
113. Conti CR. Silent cardiac ischemia. Curr Opin Cardiol 2002; 17: 537-542. (Pubitemid 35265793)
114. Abe T, Morgan DA, Gutterman DD. Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation. Circulation 1997; 95: 213-220. (Pubitemid 27029965)